Exercise-induced platelet aggregation in angina and its possible prevention by beta 1-selective blockade
- PMID: 1977586
- DOI: 10.1093/oxfordjournals.eurheartj.a059802
Exercise-induced platelet aggregation in angina and its possible prevention by beta 1-selective blockade
Abstract
Moderate exercise increased platelet aggregability of 12 middle-aged men with stable angina pectoris: the mean ADP threshold fell from 4.58 +/- 0.63 to 3.18 +/- 0.41 microM, P less than 0.01. Exercise did not, however, alter platelet aggregability in 12 healthy matched controls. Physical effort approximately doubled the plasma levels of adrenaline and noradrenaline in patients as well as in controls. Under the same conditions the cAMP content of platelets fell in the angina group from 20.86 +/- 1.86 to 17.78 +/- 1.71 pmol 10(-9) platelets, P less than 0.01, while there was no change in control levels. The fall of cAMP could account for the observed increase in platelet aggregability. We speculate that the increased aggregability of platelets in the exercising anginal subjects represents an imbalance between prostacyclin release and haemodynamic changes. The beta 1-selective blocker metoprolol, in usual therapeutic dosages, prevented the observed platelet changes probably by minimizing the haemodynamic disturbances and stimulating release of prostacyclin.
Similar articles
-
Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.Am J Cardiol. 1995 Jan 1;75(1):1-6. doi: 10.1016/s0002-9149(99)80516-5. Am J Cardiol. 1995. PMID: 7801853 Clinical Trial.
-
Differential effects of timolol and metoprolol on platelet function at rest and during exercise.Eur J Clin Pharmacol. 1988;33(6):587-92. doi: 10.1007/BF00542492. Eur J Clin Pharmacol. 1988. PMID: 2896594
-
The effect of beta-blockade on platelet function and fibrinolytic activity.J Cardiovasc Pharmacol. 1987;10 Suppl 2:S94-8; discussion S99. J Cardiovasc Pharmacol. 1987. PMID: 2481178
-
Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls.Eur Heart J. 1997 May;18(5):807-15. doi: 10.1093/oxfordjournals.eurheartj.a015346. Eur Heart J. 1997. PMID: 9152651
-
Beta 1-blockade and acute coronary ischemia. Possible role of platelets.Circulation. 1991 Dec;84(6 Suppl):VI68-71. Circulation. 1991. PMID: 1959217 Review.
Cited by
-
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006. Drugs. 1992. PMID: 1374320 Review.
-
Lack of interaction of ketoprofen with warfarin.Eur J Clin Pharmacol. 1993;44(2):205-6. doi: 10.1007/BF00315483. Eur J Clin Pharmacol. 1993. PMID: 8453969 Clinical Trial.
-
Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation.Eur J Clin Pharmacol. 1992;42(4):413-21. doi: 10.1007/BF00280128. Eur J Clin Pharmacol. 1992. PMID: 1387607 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical